1. Home
  2. BNR vs RDCM Comparison

BNR vs RDCM Comparison

Compare BNR & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$21.26

Market Cap

233.6M

Sector

Health Care

ML Signal

HOLD

Logo Radcom Ltd.

RDCM

Radcom Ltd.

N/A

Current Price

$13.14

Market Cap

215.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
BNR
RDCM
Founded
2014
1985
Country
China
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
233.6M
215.2M
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
BNR
RDCM
Price
$21.26
$13.14
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
66.8K
73.6K
Earning Date
11-20-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.57
EPS
N/A
0.64
Revenue
$75,749,382.00
$68,901,000.00
Revenue This Year
$136.32
$18.86
Revenue Next Year
N/A
$11.39
P/E Ratio
N/A
$20.97
Revenue Growth
5.56
17.27
52 Week Low
$2.18
$9.88
52 Week High
$24.18
$15.98

Technical Indicators

Market Signals
Indicator
BNR
RDCM
Relative Strength Index (RSI) 56.39 49.62
Support Level $19.49 $12.81
Resistance Level $24.18 $13.64
Average True Range (ATR) 1.90 0.47
MACD 0.05 0.01
Stochastic Oscillator 56.56 32.95

Price Performance

Historical Comparison
BNR
RDCM

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About RDCM Radcom Ltd.

Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.

Share on Social Networks: